PAPER Smith R, Strandberg O, Mattsson-Carlgren N, Leuzy A, Palmqvist S, Pontecorvo MJ, Devous MD, Ossenkoppele R, Hansson O

The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.

Brain. 2020 Dec 1;143(12):3805-3815. PubMed: 33439987

PAPER Kakinen A, Javed I, Davis TP, Ke PC

In vitro and in vivo models for anti-amyloidosis nanomedicines.

Nanoscale Horiz. 2021 Feb 1;6(2):95-119. Epub 2021 Jan 13 PubMed: 33438715

PAPER Arber C, Lovejoy C, Harris L, Willumsen N, Alatza A, Casey JM, Lines G, Kerins C, Mueller AK, Zetterberg H, Hardy J, Ryan NS, Fox NC, Lashley T, Wray S

Familial Alzheimer's Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis.

Cell Rep. 2021 Jan 12;34(2):108615. PubMed: 33440141

PAPER Innok W, Hiranrat A, Chana N, Rungrotmongkol T, Kongsune P

In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.

J Comput Aided Mol Des. 2021 Mar;35(3):325-336. Epub 2021 Jan 13 PubMed: 33439402

PAPER Wu J, Shao C, Ye X, Di X, Li D, Zhao H, Zhang B, Chen G, Liu HK, Qian Y

InVivo Brain Imaging of Amyloid-β Aggregates in Alzheimer's Disease with a Near-Infrared Fluorescent Probe.

ACS Sens. 2021 Mar 26;6(3):863-870. Epub 2021 Jan 13 PubMed: 33438997

PAPER Talebi M, Talebi M, Kakouri E, Farkhondeh T, Pourbagher-Shahri AM, Tarantilis PA, Samarghandian S

Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases.

Int J Biol Macromol. 2021 Mar 1;172:93-103. Epub 2021 Jan 10 PubMed: 33440210

PAPER Lissek V, Suchan B

Preventing dementia? Interventional approaches in mild cognitive impairment.

Neurosci Biobehav Rev. 2021 Mar;122:143-164. Epub 2021 Jan 10 PubMed: 33440197

PAPER Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, Kilpert F, Ten Kate M, Barkhof F, Tsolaki M, Verhey FR, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Bertram L, Lovestone S, Streffer J, Vos S, Bos I, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Blennow K, Scheltens P, Teunissen CE, Zetterberg H, Visser PJ

Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.

Brain. 2020 Dec 1;143(12):3776-3792. PubMed: 33439986

Lea T. Grinberg on A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP.

COMMENT In frontotemporal dementia, tau and TDP43 rarely appear together. People with #FTLD-TDP and TMEM106B polymorphism A/A have an odds ratio of 13.9 (crude) or 31.3 (multivariate) to develop a distinct 4R tauopathy. We investigated 90 FTLD-TDP cases—all types ...

Expression Analysis Uncovers Three Distinct Forms of Alzheimer’s

RESEARCH NEWS 2021-01-14 Research News Alzheimer’s disease comes in distinct molecular flavors, according to a study in the January 6 Science Advances. Researchers led by Bin Zhang at Icahn School of Medicine at Mount Sinai, New York, compared bulk RNA-Seq data from AD and ...

PAPER

Human genome meeting 2016: Houston, TX, USA. 28 February- 2 March 2016.

Hum Genomics. 2016 May 26;10 Suppl 1:12. PubMed: 27294413

Neuro> 2021: The CurePSP International Research Symposium (Virtual Meeting)

CONFERENCE 2021-02-04 00:00:00-2021-02-05 00:00:00 Online Meeting 04 &#x2013 05 February 2021 View Conference Website 0 ...

SEARCH RESULTS